Overview
Daiichi Sankyo is a leader in the Japanese pharmaceuticals business. The company manufactures prescription drugs, including treatments for cardiovascular, bone and joint, autoimmune, metabolic, and infectious diseases.
Top products include Olmetec for hypertension and Loxonin for inflammation. Daiichi Sankyo also makes over-the-counter (OTC) and generic drugs through subsidiaries including Daiichi Sankyo Healthcare and majority owned Ranbaxy Laboratories.
